Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Cytoplasmic Lattices: Massive Storage in Oocytes

April 16, 2026
Continue Reading
cytoplasmic-lattices:-massive-storage-in-oocytes
Posted inBiotechnology

Pink-1 Mutation Sparks Gut, Brain Cell Damage

April 16, 2026
Continue Reading
pink-1-mutation-sparks-gut,-brain-cell-damage
Posted inBiotechnology

Ultra-Stretchable, Anti-Freezing Hydrogel Electrolytes Cross-Linked with Liquid Metal Particle Initiators for Advanced Soft Energy Storage Devices

April 16, 2026
Continue Reading
ultra-stretchable,-anti-freezing-hydrogel-electrolytes-cross-linked-with-liquid-metal-particle-initiators-for-advanced-soft-energy-storage-devices
Posted inBiotechnology

Amplifying Voices: Advances in Vocal Fold Regeneration

April 16, 2026
Continue Reading
amplifying-voices:-advances-in-vocal-fold-regeneration
Posted inBiotechnology

Scientists Develop Multiscale Electrode Design to Boost Hydrogen Production Efficiency

April 16, 2026
Continue Reading
scientists-develop-multiscale-electrode-design-to-boost-hydrogen-production-efficiency
Posted inBiotechnology

Carbonyl Swapping Transforms Ketones into Saturated Heterocycles

April 16, 2026
Continue Reading
carbonyl-swapping-transforms-ketones-into-saturated-heterocycles
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

fda-rejects-zealand-pharma’s-glp-2-analog-in-rare-bowel-disease
Posted inBiotechnology

FDA rejects Zealand Pharma’s GLP-2 analog in rare bowel disease

December 19, 2024
The FDA has denied Zealand Pharma’s approval bid for glepaglutide—a possible challenger to Takeda’s Gattex—in short bowel syndrome (SBS), citing…
Read More
flu-vaccine-response-boosted-by-coupling-antigens-from-multiple-subtypes
Posted inGenetics

Flu Vaccine Response Boosted by Coupling Antigens from Multiple Subtypes

December 19, 2024
The seasonal influenza vaccine contains strains of viruses from distinct virus subtypes, but most people who are vaccinated will mount…
Read More
pyxis-oncology-shelves-antibody-to-focus-on-sole-clinical-asset,-an-adc-licensed-from-pfizer
Posted inBiotechnology

Pyxis Oncology shelves antibody to focus on sole clinical asset, an ADC licensed from Pfizer

December 19, 2024
Pyxis Oncology is shelving a clinical-stage monoclonal antibody to focus on its lead antibody-drug conjugate (ADC) after sharing preliminary results…
Read More
oncology-biotech-epitopea-licenses-genevant-nucleic-acid-delivery-tech-for-up-to-$123m
Posted inBiotechnology

Oncology biotech Epitopea licenses Genevant nucleic acid delivery tech for up to $123M

December 19, 2024
To develop RNA medicines targeting a proprietary bundle of tumor antigens, Epitopea is tapping nucleic acid delivery specialist Genevant Sciences…
Read More
chutes-&-ladders—fda’s-principal-deputy-to-depart-agency
Posted inBiotechnology

Chutes & Ladders—FDA’s principal deputy to depart agency

December 19, 2024
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please…
Read More
omeros-antibody-improves-overall-survival-by-68%-in-rare-condition,-new-analysis-finds
Posted inBiotechnology

Omeros antibody improves overall survival by 68% in rare condition, new analysis finds

December 19, 2024
Omeros is putting up its monoclonal antibody up for FDA approval—again. This time, the resubmission will be based on a…
Read More
merck’s-hiv-combo-treatment-meets-the-bar-for-viral-suppression-in-pair-of-phase-3-studies
Posted inBiotechnology

Merck’s HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies

December 19, 2024
After hitting the mark in a phase 2 of its investigational islatravir paired with Gilead’s lenacapivir, Merck & Co.'s islatravir…
Read More
vc-firm-pens-$608m-biobucks-deal-to-redirect-ngm’s-mash-drug-to-rare-disease
Posted inBiotechnology

VC firm pens $608M biobucks deal to redirect NGM’s MASH drug to rare disease

December 19, 2024
KdT Ventures has signed off on a $608 million biobucks deal for NGM Biopharmaceuticals’ phase 2-ready metabolic-dysfunction associated steatohepatitis (MASH)…
Read More
scinai-immunotherapeutics-establishes-us.-cdmo-subsidiary
Posted inGenetics

Scinai Immunotherapeutics Establishes U.S. CDMO Subsidiary

December 19, 2024
Scinai Immunotherapeutics, which focuses on developing inflammation and immunology biological products and providing CDMO services through its Scinai Bioservices business…
Read More
regeneron-anticoagulant-bests-enoxaparin,-matches-eliquis-in-phase-2-trial
Posted inBiotechnology

Regeneron anticoagulant bests enoxaparin, matches Eliquis in phase 2 trial

December 19, 2024
A pair of Regeneron’s monoclonal antibodies have held their own against a commonly used anticoagulant in a phase 2 trial,…
Read More

Posts pagination

Previous page 1 … 1,678 1,679 1,680 1,681 1,682 … 1,693 Next page
You May Have Missed
labcorp-launches-rapid-fentanyl-test-with-48-hour-detection-window
Posted inMedical Technology

Labcorp launches rapid fentanyl test with 48-hour detection window

click-therapeutics-cuts-staff-after-commercial-deal-restructuring
Posted inMedical Technology

Click Therapeutics cuts staff after commercial deal restructuring

stryker-makes-a-buy-as-avalon-to-go-private-in-a-spate-of-medtech-m&a-deals
Posted inMedical Technology

Stryker makes a buy as Avalon to go private in a spate of medtech M&A deals

alamar-biosciences-files-for-ipo-amid-opening-life-sciences-funding-window
Posted inMedical Technology

Alamar Biosciences files for IPO amid opening life sciences funding window

Privacy Policy    Terms

Scroll to Top